Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
2005 · The Lancet · 3,419 citations
https://doi.org/10.1016/s0140-6736(05)71142-9
E
E. Joanna Baxter
Institut thématique Immunologie, inflammation, infectiologie et microbiologie(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
94
Papers
13.6K
Citations
32
h-index
48
i10-index
E. Joanna Baxter is an academic researcher from Institut thématique Immunologie, inflammation, infectiologie et microbiologie. The author has contributed to research in topics: Myeloproliferative Neoplasms: Diagnosis and Treatment & Acute Myeloid Leukemia Research & Chronic Myeloid Leukemia Treatments. The author has an h-index of 32, co-authored 80 publications.
ORCID: 0000-0002-5946-5238Papers by this author
worksClassification and Personalized Prognosis in Myeloproliferative Neoplasms
2018 · New England Journal of Medicine · 586 citations
https://doi.org/10.1056/nejmoa1716614
Inherited polygenic effects on common hematological traits influence clonal selection on JAK2V617F and the development of myeloproliferative neoplasms
2024 · Nature Genetics · 19 citations
https://doi.org/10.1038/s41588-023-01638-x
Treatment of acute myeloid leukemia models by targeting a cell surface RNA-binding protein
2025 · Nature Biotechnology · 16 citations
https://doi.org/10.1038/s41587-025-02648-2
Dynamic variation of CD5 surface expression levels within individual chronic lymphocytic leukemia clones
2016 · Experimental Hematology · 13 citations
https://doi.org/10.1016/j.exphem.2016.09.010
Timing and trajectory of BCR::ABL1-driven chronic myeloid leukaemia
2025 · Nature · 10 citations
https://doi.org/10.1038/s41586-025-08817-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat